Trials Sponsors Conditions Drugs Pricing

Conditions

Borderline Personality Disorder Generalized Anxiety Disorder Major Depressive Disorder

Outcome Measures

Primary Outcomes (1)

The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study
Up to 52 weeks

Secondary Outcomes (2)

The proportion of participants who enroll in industry-sponsored clinical trials
Up to 52 weeks
The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials
Up to 52 weeks

Interventions

SurveyOther

Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Participants of any sex, age 18+, who have expressed interest in participating in an industry-sponsored clinical trial of an investigational product for indications in psychiatry will be screened for clinical appropriateness for a study trial.

You may qualify if:

Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.

Sponsors & Collaborators

Adams Clinical
Research networklead

Study Sites (6)

Adams Clinical, Boston

Boston, Massachusetts, 02116, United States

RECRUITING

Karla Meehan, MACONTACT617-209-3469 kmeehan@adamsclinical.com

Dyanna Domilici, MDPRINCIPAL INVESTIGATOR

Adams Clinical, Watertown

Watertown, Massachusetts, 02472, United States

RECRUITING

Miriam Evans, PhDCONTACT

MeSH Terms

Conditions

Depressive Disorder, MajorBorderline Personality DisorderGeneralized Anxiety Disorder

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersPersonality DisordersAnxiety Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative Techniques

Central Study Contacts

Miriam Evans, PhD

CONTACT

617-744-8542 mevans@adamsclinical.com

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: NETWORK
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 24, 2023

First Posted

April 6, 2023

Study Start

December 21, 2021

Actual (reported)

Primary Completion

December 31, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Triage Survey for Psychiatry Research Eligibility

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (6)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (6)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations